PKI-179 hydrochloride is a potent and orally active dual PI3K/mTOR inhibitor with antitumor activity in vivo; it effectively inhibits PI3K-α, PI3K-β, PI3K-γ, PI3K-δ, and mTOR (IC50 values of 8 nM, 24 nM, 74 nM, 77 nM, and 0.42 nM, respectively), and also shows activity against the PI3K mutants E545K and H1047R (IC50 values of 14 nM and 11 nM, respectively).